Search - tctmd.com

Displaying 101 - 112 of 112

Sort: Relevancy | Date

News Conference News EuroPCR 2012

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

Caitlin E. Cox

May 22, 2012

Presentation GI2 2012

Pathology of DES with Biodegradable Polymer: Are They Really Better?

Presenter: Renu Virmani

April 12, 2012

News Daily News

EVOLVE Published: Bioabsorbable EES Matches Permanent-Polymer Version

February 21, 2012

News Daily News

Resolute Integrity: New Zotarolimus-Eluting Stent Gains FDA Approval

L.A. McKeown

February 20, 2012

Presentation TCT 2012

An All Comers Randomized Trial Comparing Xience Prime and Promus Element Stents. Preliminary Results.

Presenter: Jose M. De la Torre Hernandez, Tamara Garcia Camarero, Piedad Lerena, Dae-Hyun Lee, Fermin Sainz Laso, Virginia Frances Santamaria, Monica Fernandez Menendez, Gonzalo Martin Gorria, Javier Zueco

January 03, 2012

News Conference News

Landmark Analyses Show Downside of Prolonged Antiplatelet Therapy

September 02, 2011

News Daily News

Selective Use of DES Saves Millions of Dollars a Year

Jason Kahn

August 15, 2011

News Industry News

Study Confirms that OrbusNeich's GenousTM Stent Effectively Captures Circulating Endothelial Progenitor Cells to Accelerate Re-Endothelialization and Decrease Thrombogenicity

July 11, 2011

News Conference News

Long-Term Imaging Study Evaluates Vascular Healing in First-Gen DES

Jason Kahn

May 19, 2011

News Daily News

Study Hints Stenting Tops Angioplasty Alone for Stubborn DVT

Caitlin E. Cox

May 06, 2011

News Industry News

Medtronic Resolute® Drug-Eluting Stent Delivers Compelling Clinical Outcomes in Major Studies

April 04, 2011

News Daily News

Autopsy Study: About One-Third of DES Contain New Atherosclerosis

March 01, 2011

Advertisement

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

Pathology of DES with Biodegradable Polymer: Are They Really Better?

EVOLVE Published: Bioabsorbable EES Matches Permanent-Polymer Version

Resolute Integrity: New Zotarolimus-Eluting Stent Gains FDA Approval

An All Comers Randomized Trial Comparing Xience Prime and Promus Element Stents. Preliminary Results.

Landmark Analyses Show Downside of Prolonged Antiplatelet Therapy

Selective Use of DES Saves Millions of Dollars a Year

Study Confirms that OrbusNeich's GenousTM Stent Effectively Captures Circulating Endothelial Progenitor Cells to Accelerate Re-Endothelialization and Decrease Thrombogenicity

Long-Term Imaging Study Evaluates Vascular Healing in First-Gen DES

Study Hints Stenting Tops Angioplasty Alone for Stubborn DVT

Medtronic Resolute® Drug-Eluting Stent Delivers Compelling Clinical Outcomes in Major Studies

Autopsy Study: About One-Third of DES Contain New Atherosclerosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content